85 related articles for article (PubMed ID: 10417342)
41. Endothelin-1 promotes proteolytic activity of ovarian carcinoma.
Rosanò L; Salani D; Di Castro V; Spinella F; Natali PG; Bagnato A
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():306S-309S. PubMed ID: 12193110
[TBL] [Abstract][Full Text] [Related]
42. The autoactivation of human single-chain urokinase-type plasminogen activator (uPA).
Torres-Paris C; Chen Y; Xiao L; Song HJ; Chen P; Komives EA
J Biol Chem; 2023 Oct; 299(10):105179. PubMed ID: 37607618
[TBL] [Abstract][Full Text] [Related]
43. Urinary trypsin inhibitor (UTI) and fragments derived from UTI by limited proteolysis efficiently inhibit tumor cell invasion.
Kobayashi H; Shinohara H; Ohi H; Sugimura M; Terao T; Fujie M
Clin Exp Metastasis; 1994 Mar; 12(2):117-28. PubMed ID: 8306525
[TBL] [Abstract][Full Text] [Related]
44. Hypoxia Regulates DPP4 Expression, Proteolytic Inactivation, and Shedding from Ovarian Cancer Cells.
Moffitt LR; Bilandzic M; Wilson AL; Chen Y; Gorrell MD; Oehler MK; Plebanski M; Stephens AN
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143089
[TBL] [Abstract][Full Text] [Related]
45. Influence of human luteinizing hormone on cell growth and CA 125 secretion of primary epithelial ovarian carcinomas in vitro.
Kurbacher CM; Jäger W; Kurbacher JA; Bittl A; Wildt L; Lang N
Tumour Biol; 1995; 16(6):374-84. PubMed ID: 7569684
[TBL] [Abstract][Full Text] [Related]
46. Neokyotorphin and neokyotorphin (1-4): secretion by erythrocytes and regulation of tumor cell growth.
Blishchenko EY; Mernenko OA; Yatskin ON; Ziganshin RH; Philippova MM; Karelin AA; Ivanov VT
FEBS Lett; 1997 Sep; 414(1):125-8. PubMed ID: 9305745
[TBL] [Abstract][Full Text] [Related]
47. Serum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding.
Dupont DM; Madsen JB; Hartmann RK; Tavitian B; Ducongé F; Kjems J; Andreasen PA
RNA; 2010 Dec; 16(12):2360-9. PubMed ID: 20962041
[TBL] [Abstract][Full Text] [Related]
48. Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover.
Dong Z; Saliganan AD; Meng H; Nabha SM; Sabbota AL; Sheng S; Bonfil RD; Cher ML
Neoplasia; 2008 May; 10(5):439-49. PubMed ID: 18472961
[TBL] [Abstract][Full Text] [Related]
49. Urinary-type plasminogen activator (uPA) and its receptor (uPAR) in squamous cell carcinoma of the oral cavity.
Shi Z; Stack MS
Biochem J; 2007 Oct; 407(2):153-9. PubMed ID: 17880283
[TBL] [Abstract][Full Text] [Related]
50. Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalysed release of the urinary-type-plasminogen-activator N-terminal fragment.
Fishman DA; Kearns A; Larsh S; Enghild JJ; Stack MS
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):765-9. PubMed ID: 10417342
[TBL] [Abstract][Full Text] [Related]
51. Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function.
Fischer K; Lutz V; Wilhelm O; Schmitt M; Graeff H; Heiss P; Nishiguchi T; Harbeck N; Kessler H; Luther T; Magdolen V; Reuning U
FEBS Lett; 1998 Oct; 438(1-2):101-5. PubMed ID: 9821967
[TBL] [Abstract][Full Text] [Related]
52. Differential inhibition of endothelial cell proliferation and migration by urokinase subdomains: amino-terminal fragment and kringle domain.
Kim KS; Hong YK; Lee Y; Shin JY; Chang SI; Chung SI; Joe Y
Exp Mol Med; 2003 Dec; 35(6):578-85. PubMed ID: 14749538
[TBL] [Abstract][Full Text] [Related]
53. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.
Zhu F; Jia S; Xing G; Gao L; Zhang L; He F
DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166
[TBL] [Abstract][Full Text] [Related]
54. A bifunctional hybrid molecule of the amino-terminal fragment of urokinase and domain II of bikunin efficiently inhibits tumor cell invasion and metastasis.
Kobayashi H; Sugino D; She MY; Ohi H; Hirashima Y; Shinohara H; Fujie M; Shibata K; Terao T
Eur J Biochem; 1998 May; 253(3):817-26. PubMed ID: 9654084
[TBL] [Abstract][Full Text] [Related]
55. EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor.
Henic E; Sixt M; Hansson S; Høyer-Hansen G; Casslén B
Gynecol Oncol; 2006 Apr; 101(1):28-39. PubMed ID: 16263158
[TBL] [Abstract][Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
